Hassan Fred
SEC-identified person · CIK 1110744 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Director | filed 2021–2026 |
| Precigen, INC. XON | Director | filed 2016–2026 |
| Cocrystal Pharma, Inc. COCP | Director | filed 2023–2026 |
| Psivida LTD PSDV | Director | filed 2024–2026 |
| Prometheus Biosciences, Inc. RXDX | Director | filed 2021–2023 |
| Amgen INC AMGN | Director | filed 2015–2020 |
| Warner Media, LLC TWX | Director | filed 2009–2018 |
| Valeant Pharmaceuticals International, Inc. vrx | Director | filed 2013–2013 |
| Avon Products INC AVP | Director | filed 2006–2012 |
| Schering Plough Corp SGP | Director · Chairman and CEO | filed 2006–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.